摘要
Acta Pharmaceutica Sinica B(APSB)has been accepted for inclusion in Pub Med Central(PMC),the world’s largest and most-used biomedical literature database.Currently,papers published from Volume 4 onwards can be searched in Pub Med.PMC,launched in February 2000,is a freely-available database of full-text articles on life sciences and biomedical topics.Journals accepted to
